Schedule 13G ownership disclosure
ADVAXIS INC
Security class unavailable · CUSIP: 007624307
Event date: 2019-04-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 600,000
- Percent of class
- 7.4900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-19-000075
- Form type
- SC 13G
- Filer
- Ayala Pharmaceuticals, Inc.
- CIK
- CIK 1100397
- Filed
- Apr 03, 2019
- Reporting period
- Apr 03, 2019
- Description
- Schedule 13G beneficial ownership